# Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/tirzepatide-versus-semaglutide-once-weekly-in-patients-with-type-2-diabetes/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Juan P. Frías,Melanie J. Davies,Julio Rosenstock,Federico C. Pérez Manghi,Laura Fernández Landó,Brandon K. Bergman,Bing Liu,Xuewei Cui,Katelyn Brown |
| Citations | 1,951 |
| DOI | 10.1056/nejmoa2107519 |
| Fields | Medicine |
| Open Access | true |
| OA Status | green |
| OA URL | https://figshare.com/articles/journal_contribution/Tirzepatide_versus_Semaglutide_Once_Weekly_in_Patients_with_Type_2_Diabetes/16972132 |
| OpenAlex ID | https://openalex.org/W3177122952 |
| PMID | 34170647 |
| Type | article |
| Year | 2021 |

## Paper authors

- [Melanie J. Davies](https://scholariq.org/researchers/melanie-j-davies/)
- [Julio Rosenstock](https://scholariq.org/researchers/julio-rosenstock/)

## Paper journal

- [New England Journal of Medicine](https://scholariq.org/journals/new-england-journal-of-medicine/)

## Paper primary topic

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)

## Paper topics

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Diabetes, Cardiovascular Risks, and Lipoproteins](https://scholariq.org/topics/diabetes-cardiovascular-risks-and-lipoproteins/)
- [Hyperglycemia and glycemic control in critically ill and hospitalized patients](https://scholariq.org/topics/hyperglycemia-and-glycemic-control-in-critically-ill-and-hospitalized-patients/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.